[
  {
    "criterion": "Provides overly technical or complicated information that is difficult for a non-expert to understand.",
    "axis": "communication_quality",
    "point": -5
  },
  {
    "criterion": "Falsely indicates that the new lupus nephritis guideline is a randomized controlled trial.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Asks the user what they would like to know about the guideline to seek more relevant context.",
    "axis": "context_awareness",
    "point": 6
  },
  {
    "criterion": "Correctly highlights the limitations of the observational evidence supporting the new immunosuppression protocol.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Does not mention the potential impact of the new guideline on pregnant lupus patients.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Provides a clear explanation of the main changes from older guidelines and controversies.",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly assumes that big pharma is always behind changes in medical guidelines.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Advises seeking additional information from trusted sources, such as peer-reviewed articles.",
    "axis": "completeness",
    "point": 7
  },
  {
    "criterion": "Mentions the importance of considering individual patient experiences and alternative approaches.",
    "axis": "context_awareness",
    "point": 5
  }
]